13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Folic Acid and ASDs: A Preventive Measure against Potential Effects of Pesticide Exposures?

      article-commentary
      Environmental Health Perspectives
      Environmental Health Perspectives

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Prenatal exposures to certain household and agricultural pesticides have been associated with increased risk of autism spectrum disorders (ASDs).1 Meanwhile, a separate body of research demonstrates that taking folic acid (FA) early in pregnancy may protect against these disorders.1 , 2 A new study joins the two bodies of research, suggesting that FA may reduce—but not completely offset—the ASD risk associated with prenatal pesticide exposure.3 ASDs encompass a group of developmental disorders characterized by difficulties in communicating and interacting with other people, repetitive behaviors, and restricted interests and activities.4 Symptoms typically appear by 2 years of age, but the foundations of these disorders may be established well before birth. Genetic factors appear to influence ASD development, and environmental factors have also been identified as contributing to ASD risk.1 , 4 “Many genes have been identified as risk factors for autism, but none of them are a smoking gun,” says Rebecca J. Schmidt, first author on the new study and an assistant professor in the Department of Public Health Sciences at the University of California, Davis. “I think it is very complex—probably an interaction between genes and environment and different environmental exposures—and, of course, timing plays a big role in all of this.” With regard to timing, the first months of pregnancy are a critical period for neurodevelopment. Both exposure to certain pesticides and poor maternal nutrition at this time have been associated with increased risk of neurodevelopmental disorders.1 , 5 A lack of dietary folate (vitamin B 9 ) in early pregnancy is a known cause of central nervous system defects.6 , 7 Supplementation with FA, a synthetic form of folate, has therefore become a standard preventative approach.8 , 9 Although U.S. women of childbearing age typically get their folate from supplements, there are lots of vegetables, legumes, and other foods that can provide this important vitamin. It is especially important that women who might become pregnant get plenty of folate every day—before they conceive. Image: © RyanJLane/iStockphoto. Photograph of a young couple shopping for produce. The study used data from the ongoing Childhood Autism Risks from Genetics and the Environment (CHARGE) study, a population-based case–control investigation.10 Children with an ASD and those with typical development were enrolled between ages 2 and 5 years, and their mothers provided information about their household pesticide use, diet, and consumption of vitamin and mineral supplements from 3 months prior to conception onward. The current study included 296 children with ASDs and 220 with typical development for whom there were data on maternal use of FA supplementation and estimated exposures to household pesticides. The authors also estimated exposure to agricultural pesticides based on reports collected by the California Department of Pesticide Regulation11 cross-referenced against maternal residence during pregnancy. For each category of pesticide exposure (indoor sprays or foggers, pet flea and tick products, any indoor pesticides, outdoor sprays or foggers, any household pesticides, or any household or agricultural pesticides) the researchers compared two groups of children: those who had some type of pesticide exposure and either high or low maternal FA intake (at least 800 μg/day and below 800 μg/day , respectively), and those without pesticide exposure whose mothers had high FA intake. For each type of pesticide, children with pesticide exposure and low maternal FA intake were at least twice as likely to have an ASD as those with no exposure and high maternal FA intake.3 Among U.S. women of childbearing age, supplements are typically a larger source than diet for FA intake.12 The authors did not examine all sources of dietary folate, although they did include fortified foods including cereals, breakfast shakes, and protein bars. “I think the positive aspect of this study is that we might, in a way, prevent exposure-related risk by different nutritional intake through supplements,” says Marija Kundakovic, an assistant professor in biological sciences at Fordham University, who was not involved in the study. Nevertheless, the authors advise avoiding pesticide exposures during pregnancy. “Even though this study supports that folic acid might attenuate the risk associated with pesticides, it did not completely eliminate it,” says Schmidt. The use of well-confirmed ASD cases is a strength of the study, whereas limitations include self-reported exposure information and potential recall bias, a lack of comprehensive exposure data, and the potential for unmeasured confounding by other factors. The researchers speculated that the potentially protective mechanism may involve the epigenome, a collection of small chemical tags, such as methyl groups, that punctuate the language of the genetic code and influence gene expression and silencing. Because FA is a methyl donor, this mechanism (among others) warrants further exploration in larger studies that include exposure measurements. Larissa Takser, an associate professor of pediatrics at the Université du Sherbrooke in Quebec, points out that the study was based on existing evidence and that it is already known that many pesticides are neurotoxic in humans. “Now we need more human research, especially prospective studies, to test contaminant–nutritional interactions,” she says. “ASDs are very serious lifetime conditions, and more effort should be invested in promising preventive strategies.”

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children.

          Prenatal folic acid supplements reduce the risk of neural tube defects in children, but it has not been determined whether they protect against other neurodevelopmental disorders. To examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disorder, Asperger syndrome, pervasive developmental disorder-not otherwise specified [PDD-NOS]) in children. The study sample of 85,176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity. Specialist-confirmed diagnosis of ASDs. At the end of follow-up, 270 children in the study sample had been diagnosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS. In children whose mothers took folic acid, 0.10% (64/61,042) had autistic disorder, compared with 0.21% (50/24,134) in those unexposed to folic acid. The adjusted OR for autistic disorder in children of folic acid users was 0.61 (95% CI, 0.41-0.90). No association was found with Asperger syndrome or PDD-NOS, but power was limited. Similar analyses for prenatal fish oil supplements showed no such association with autistic disorder, even though fish oil use was associated with the same maternal characteristics as folic acid use. Use of prenatal folic acid supplements around the time of conception was associated with a lower risk of autistic disorder in the MoBa cohort. Although these findings cannot establish causality, they do support prenatal folic acid supplementation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism

            Causes and contributing factors for autism are poorly understood. Evidence suggests that prevalence is rising, but the extent to which diagnostic changes and improvements in ascertainment contribute to this increase is unclear. Both genetic and environmental factors are likely to contribute etiologically. Evidence from twin, family, and genetic studies supports a role for an inherited predisposition to the development of autism. Nonetheless, clinical, neuroanatomic, neurophysiologic, and epidemiologic studies suggest that gene penetrance and expression may be influenced, in some cases strongly, by the prenatal and early postnatal environmental milieu. Sporadic studies link autism to xenobiotic chemicals and/or viruses, but few methodologically rigorous investigations have been undertaken. In light of major gaps in understanding of autism, a large case–control investigation of underlying environmental and genetic causes for autism and triggers of regression has been launched. The CHARGE (Childhood Autism Risks from Genetics and Environment) study will address a wide spectrum of chemical and biologic exposures, susceptibility factors, and their interactions. Phenotypic variation among children with autism will be explored, as will similarities and differences with developmental delay. The CHARGE study infrastructure includes detailed developmental assessments, medical information, questionnaire data, and biologic specimens. The CHARGE study is linked to University of California–Davis Center for Children’s Environmental Health laboratories in immunology, xenobiotic measurement, cell signaling, genomics, and proteomics. The goals, study design, and data collection protocols are described, as well as preliminary demographic data on study participants and on diagnoses of those recruited through the California Department of Developmental Services Regional Center System.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The Epigenetic Link between Prenatal Adverse Environments and Neurodevelopmental Disorders

              Prenatal adverse environments, such as maternal stress, toxicological exposures, and viral infections, can disrupt normal brain development and contribute to neurodevelopmental disorders, including schizophrenia, depression, and autism. Increasing evidence shows that these short- and long-term effects of prenatal exposures on brain structure and function are mediated by epigenetic mechanisms. Animal studies demonstrate that prenatal exposure to stress, toxins, viral mimetics, and drugs induces lasting epigenetic changes in the brain, including genes encoding glucocorticoid receptor (Nr3c1) and brain-derived neurotrophic factor (Bdnf). These epigenetic changes have been linked to changes in brain gene expression, stress reactivity, and behavior, and often times, these effects are shown to be dependent on the gestational window of exposure, sex, and exposure level. Although evidence from human studies is more limited, gestational exposure to environmental risks in humans is associated with epigenetic changes in peripheral tissues, and future studies are required to understand whether we can use peripheral biomarkers to predict neurobehavioral outcomes. An extensive research effort combining well-designed human and animal studies, with comprehensive epigenomic analyses of peripheral and brain tissues over time, will be necessary to improve our understanding of the epigenetic basis of neurodevelopmental disorders.
                Bookmark

                Author and article information

                Journal
                Environ Health Perspect
                Environ. Health Perspect
                EHP
                Environmental Health Perspectives
                Environmental Health Perspectives
                0091-6765
                1552-9924
                23 October 2017
                October 2017
                : 125
                : 10
                : 104006
                Article
                EHP2474
                10.1289/EHP2474
                5933317
                29061544
                376e8f75-c0f7-4271-b549-c8fec9cb9f4c

                EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.

                History
                : 06 July 2017
                : 06 July 2017
                Categories
                Science Selection

                Public health
                Public health

                Comments

                Comment on this article